1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.75%
Positive revenue growth while 5715.T is negative. John Neff might see a notable competitive edge here.
65.99%
Positive gross profit growth while 5715.T is negative. John Neff would see a clear operational edge over the competitor.
52.93%
Positive EBIT growth while 5715.T is negative. John Neff might see a substantial edge in operational management.
59.53%
Positive operating income growth while 5715.T is negative. John Neff might view this as a competitive edge in operations.
39.28%
Positive net income growth while 5715.T is negative. John Neff might see a big relative performance advantage.
39.31%
Positive EPS growth while 5715.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
39.31%
Positive diluted EPS growth while 5715.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Reduced diluted shares while 5715.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-95.18%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-56.35%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-48.31%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
97.04%
Positive 10Y CAGR while 5715.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-100.43%
Negative 5Y net income/share CAGR while 5715.T is 109.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1159.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
218.02%
5Y equity/share CAGR above 1.5x 5715.T's 51.23%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
12.04%
3Y equity/share CAGR at 50-75% of 5715.T's 20.96%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.17%
AR growth well above 5715.T's 5.50%. Michael Burry fears inflated revenue or higher default risk in the near future.
30.87%
We show growth while 5715.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
18.56%
Positive asset growth while 5715.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.04%
We have a declining book value while 5715.T shows 1.98%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
63.62%
Debt growth far above 5715.T's 1.05%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-41.99%
We cut SG&A while 5715.T invests at 2.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.